Switch to:
NovaBay Pharmaceuticals Inc (AMEX:NBY)
EV/EBITDA
-2.05 (As of Today)

EV/EBITDA ratio is calculated as enterprise value divided by its EBITDA. As of today, NovaBay Pharmaceuticals Inc's enterprise value is $37.20 Mil. NovaBay Pharmaceuticals Inc's earnings before depreciation and amortization for the trailing twelve months (TTM) ended in Jun. 2016 was $-18.17 Mil. Therefore, NovaBay Pharmaceuticals Inc's EV/EBITDA ratio for today is -2.05.

NBY' s EV/EBITDA Range Over the Past 10 Years
Min: -59.6   Max: 46
Current: -2.05

-59.6
46

During the past 12 years, the highest EV/EBITDA Ratio of NovaBay Pharmaceuticals Inc was 46.00. The lowest was -59.60. And the median was -2.75.

NBY's EV/EBITDA is ranked lower than
99.99% of the 264 Companies
in the Global Biotechnology industry.

( Industry Median: 20.40 vs. NBY: -2.05 )

EV/EBITDA (Enterprise value/EBITDA) is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the P/E Ratio to determine the fair market value of a company.

As of today, NovaBay Pharmaceuticals Inc's stock price is $3.57. NovaBay Pharmaceuticals Inc's earnings per share for the trailing twelve months (TTM) ended in Jun. 2016 was $-4.42. Therefore, NovaBay Pharmaceuticals Inc's P/E Ratio for today is .

The "classic" EV/EBITDA ratio is much better in capturing debt and net cash than the P/E Ratio.


Definition

NovaBay Pharmaceuticals Inc's EV/EBITDA for today is calculated as:

EV/EBITDA=Enterprise Value (Today)/Earnings Before Depreciation and Amortization (TTM)
=37.199/-18.174
=-2.05

NovaBay Pharmaceuticals Inc's current Enterprise Value is $37.20 Mil.
NovaBay Pharmaceuticals Inc's Earnings Before Depreciation and Amortization for the trailing twelve months (TTM) ended in Jun. 2016 was -5.307 (Sep. 2015 ) + -6.105 (Dec. 2015 ) + -4.584 (Mar. 2016 ) + -2.178 (Jun. 2016 ) = $-18.17 Mil.

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.


Explanation

EV/EBITDA (Enterprise value/EBITDA) is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the P/E Ratio to determine the fair market value of a company.

NovaBay Pharmaceuticals Inc's P/E Ratio for today is calculated as:

P/E Ratio=Share Price (Today)/Earnings Per Share (TTM)
=3.57/-4.42
=

NovaBay Pharmaceuticals Inc's share price for today is $3.57.
NovaBay Pharmaceuticals Inc's Earnings Per Share for the trailing twelve months (TTM) ended in Jun. 2016 was -1.75 (Sep. 2015 ) + -1.07 (Dec. 2015 ) + -1.24 (Mar. 2016 ) + -0.36 (Jun. 2016 ) = $-4.42.

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.

Study has found that the companies with the lowest EV/EBITDA outperforms companies measured as cheap by other ratios such as P/E Ratio.

Please read Which price ratio outperforms the enterprise multiple?


Related Terms

Enterprise Value, Earnings Before Depreciation and Amortization, P/E Ratio


Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.

NovaBay Pharmaceuticals Inc Annual Data

Dec06Dec07Dec08Dec09Dec10Dec11Dec12Dec13Dec14Dec15
ev2ebitda 0.00-10.25-1.2511.87-6.43-6.17-3.13-2.75-1.63-0.30

NovaBay Pharmaceuticals Inc Quarterly Data

Mar14Jun14Sep14Dec14Mar15Jun15Sep15Dec15Mar16Jun16
ev2ebitda -2.41-1.85-2.05-1.63-2.11-2.10-0.93-0.30-0.59-1.10
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK